Anjarium Biosciences AG

At Anjarium Biosciences, we are striving to create and deliver solutions for patients beyond what current gene therapy platforms address today. We do this by tackling more diseases, more precisely and in a more personalized way. Anjarium is developing a new generation of genetic medicines to overcome the greatest challenges facing the field, notably immunogenicity, payload capacity, individualized multiple dosing, targeted delivery and scaled manufacturing.